A new company has been founded to supply software for managing cell & gene therapy manufacturing.
Autolomous, founded in February 2019, has already secured four different clients whom they hope to assist with digitizing and streamlining their workflows.
“There’s a gap around handling manufacturing data in cell and gene therapy manufacturing,” explains Kwok Pang, the company’s co-founder and COO. “So, what we’re doing is providing that missing piece of the puzzle to help drive efficiency across the supply chain.”
